Juliet Masumi

Senior Research Associate II
Fremont, California, United States

Professional Overview

Juliet Masumi is a seasoned life sciences research professional with over a decade of experience driving impactful drug discovery and development initiatives. As a Senior Research Associate II at Pheast Therapeutics, she leverages her deep expertise in preclinical research, data analysis, and cross-functional collaboration to advance innovative treatment solutions for complex disease states.

Experience Summary

Current Role

As a Senior Research Associate II at Pheast Therapeutics, Juliet plays a crucial role in the company's R&D efforts. She is responsible for designing and executing state-of-the-art in vitro and in vivo studies, analyzing experimental data, and interpreting findings to inform the development of novel therapeutic candidates. Juliet's exceptional problem-solving skills, attention to detail, and ability to work collaboratively with cross-functional teams have contributed to the successful progression of several drug programs.

Career Progression

Prior to her current role, Juliet served as a Senior Research Associate at Alkahest, Inc., where she spearheaded the optimization of lead compounds and the development of advanced preclinical models. Her earlier experience includes roles as a Life Science Research Professional at Stanford University School of Medicine and a Staff Research Associate at UC Irvine, where she honed her expertise in a variety of experimental techniques and gained a deep understanding of the drug discovery and development process.

Academic Background

Juliet holds a Bachelor of Science degree in Molecular Biology from the University of California, San Diego, where she graduated with honors.

Areas of Expertise

• Proficient in the design and execution of in vitro and in vivo studies, including cell-based assays, animal models, and pharmacokinetic/pharmacodynamic analyses

• Skilled in the utilization of advanced analytical techniques, such as high-throughput screening, mass spectrometry, and molecular biology

• Experienced in the interpretation of complex data sets and the development of data-driven hypotheses to guide research strategy

• Adept at collaborating with cross-functional teams, including medicinal chemists, pharmacologists, and clinicians, to drive the progression of drug candidates

• Excellent communication and presentation skills, with the ability to effectively convey research findings to diverse stakeholders

Professional Impact

Throughout her career, Juliet has made significant contributions to the advancement of promising drug candidates, including her work on a novel small-molecule inhibitor that demonstrated promising efficacy in preclinical models of a rare neurodegenerative disorder. Her research has been published in peer-reviewed journals, and she has presented her work at leading industry conferences, further showcasing her expertise and driving scientific discourse.

Conclusion

With her deep expertise, collaborative approach, and unwavering commitment to scientific excellence, Juliet Masumi is poised to continue making valuable contributions to the development of transformative therapies that address unmet medical needs. Her strong track record of success and her dedication to advancing the field of drug discovery make her a valuable asset to the Pheast Therapeutics team.